USD 4.2
(-0.94%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | 54.15 Million USD | -9.22% |
2023 | 61.08 Million USD | 51.72% |
2022 | 40.03 Million USD | 11.17% |
2021 | 37.03 Million USD | -19.24% |
2020 | 29.58 Million USD | 251.09% |
2019 | 17.29 Million USD | -18.03% |
2018 | -12.76 Thousand USD | 373.28% |
2017 | 3.89 Million USD | 1592.07% |
2016 | -261.34 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q4 | 7.71 Million USD | -44.02% |
2024 Q3 | 12.3 Million USD | -0.21% |
2024 Q1 | 9.46 Million USD | 63.72% |
2024 Q2 | 14.8 Million USD | 69.09% |
2023 Q4 | -3.06 Million USD | -108.9% |
2023 FY | - USD | 51.72% |
2023 Q3 | 34.47 Million USD | 349.32% |
2023 Q2 | 7.67 Million USD | -62.99% |
2023 Q1 | 20.73 Million USD | 67.84% |
2022 Q3 | 4.48 Million USD | -76.86% |
2022 Q2 | 19.38 Million USD | 71.46% |
2022 Q1 | 11.3 Million USD | 30.65% |
2022 FY | - USD | 11.17% |
2022 Q4 | 12.35 Million USD | 175.33% |
2021 Q4 | 8.65 Million USD | 53.43% |
2021 Q2 | 12.3 Million USD | 34.45% |
2021 Q3 | 5.64 Million USD | -54.16% |
2021 FY | - USD | -19.24% |
2021 Q1 | 9.15 Million USD | 55.56% |
2020 Q3 | 908.58 Thousand USD | -96.54% |
2020 Q4 | 5.88 Million USD | 547.65% |
2020 Q1 | 7.33 Million USD | -78.37% |
2020 FY | - USD | 251.09% |
2020 Q2 | 26.24 Million USD | 257.89% |
2019 Q1 | -752.68 Thousand USD | -21.67% |
2019 Q2 | -987.55 Thousand USD | -31.2% |
2019 Q4 | 33.9 Million USD | 1739.57% |
2019 Q3 | -2.06 Million USD | -109.4% |
2019 FY | - USD | -18.03% |
2018 Q4 | -618.63 Thousand USD | -88.68% |
2018 FY | - USD | 373.28% |
2018 Q1 | 6.71 Million USD | 0.0% |
2018 Q3 | -327.86 Thousand USD | -2468.49% |
2018 Q2 | -12.76 Thousand USD | -100.19% |
2017 FY | - USD | 1592.07% |
2016 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Muliang Viagoo Technology, Inc. | 467.3 Thousand USD | -11488.413% |
N2OFF, Inc. | -7.51 Million USD | 820.457% |
Arcadia Biosciences, Inc. | -13.93 Million USD | 488.526% |
Yield10 Bioscience, Inc. | -14.12 Million USD | 483.328% |